FDA Investigator Yung W Chan
Yung W Chan has conducted inspections on 4 sites in 1 countries as of 09 Dec 2022. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
4
Last Inspection Date:
09 Dec 2022
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Yung W Chan:
Ana S Cabrera,
Dave M Deroche,
Dellarese L Herbert,
Derek C Price,
Ernest H Blackwood,
Frank J Marciniak,
Kinh Q Mac,
Li Li,
Mary R Hole,
Melanie W Pishnery,
Melissa A Freeman,
Melissa A Zuppe,
Miaja Umaedi,
Michael Serrano,
Michelle L Johnson,
Robert G Ruff,
Stayce E Beck,
Tania E Vizcaino,
William R Chang
Yung W Chan's Documents
Publish Date | Document Type | Title |
---|---|---|
July, 2017 | FDA 483 | Becton Dickinson & Company - Form 483, 2017-07-06 |
March, 2020 | FDA 483 | Becton Dickinson & Company - Form 483, 2020-03-17 |
March, 2019 | FDA 483 | BD Life Sciences, Preanalytical Solutions - Form 483, 2019-03-01 |
July, 2017 | EIR | Becton Dickinson & Company - EIR, 2017-07-06 |
September, 2015 | EIR | Theranos, Inc. - EIR, 2015-10-30 |
September, 2015 | FDA 483 | Theranos, Inc. - Form 483, 2015-09-16 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more